Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096421
Status:
COMPLETED
Last Update Posted:
2006-10-26
First Post:
2004-11-09
Brief Title:
Tight Glycemic Control in Critical Care Patients
Sponsor:
Hospital Pablo Tobón Uribe
Organization:
Hospital Pablo Tobón Uribe
Study Overview
Official Title:
Tight Glycemic Control in Patients Hospitalized in a Medical-Surgery Intensive Care Unit A Randomized Study
Status:
COMPLETED
Status Verified Date:
2006-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the impact of tight control of serum glucose levels with an intensive insulin treatment in patients hospitalized in an intensive care unit with medical and surgical patients
Detailed Description:
Reduction of morbidity-mortality in critical care patients with tight glycemic control had been proven in surgical patients only
Study Hypothesis In critical care patients medical or surgical a glucose serum level between 80 - 110 mgdL means a lower mortality than patients with glucose levels of more than 110 mgdL
Study Hypothesis In critical care patients medical or surgical a glucose serum level between 80 - 110 mgdL means a lower mortality than patients with glucose levels of more than 110 mgdL
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 094-2003 | None | None | None |